Moderna will apply for conditional marketing authorization with European Medicines Agency (File)

Washington:

US firm Moderna said it would file requests for authorization of its Covid-19 vaccine in the United States and Europe on Monday, after full results confirmed a high efficacy estimated at 94.1 percent.

“Moderna plans today to request EUA (Emergency Use Authorization) from the US FDA (Food and Drug Administration),” Moderna said in a statement, adding it would also “apply for a conditional marketing authorization with the European Medicines Agency (EMA).”

Newsbeep

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here